Skip to main content
Clinical Trials/NCT05106816
NCT05106816
Completed
N/A

The Effects of Vibrotactile Stimulation (Not Impossible Vibrohealth) on Motor Control and Symptoms in Patients With Movement Disorders

University of Florida1 site in 1 country40 target enrollmentOctober 7, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
University of Florida
Enrollment
40
Locations
1
Primary Endpoint
Quantitative Tremor Assessment
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Vibration applied to the skin has been anecdotally reported to potentially improve motor control in patients with movement disorders including Parkinson's disease, however few devices have been studied formally. In this study, the investigators will test the effect of skin surface vibration applied non-invasively to patients with movement disorders to determine if there are any beneficial effects on common tasks of motor control and/or abnormal motor symptoms in patients with Parkinson's disease (PD), essential tremor (ET), and dystonia.

Detailed Description

This study is to evaluate the feasibility, reliability, and clinical effects of Non-invasive vibrotactile stimulation (VTS) on basic tasks of motor control and on the motor symptoms of patients with movement disorders. VTS Settings will include continuous stimulation, intermittent stimulation during walking, and sham stimulation. The investigators will recruit 30 patients with PD who are between the ages of 18-80 years old and independently living in the community. The investigators will additionally recruit up to 5 patients with ET and up to 5 patients with dystonia.

Registry
clinicaltrials.gov
Start Date
October 7, 2021
End Date
September 20, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18-80 and able to provide informed consent.
  • Have a diagnosis of Parkinson's disease, essential tremor, or cervical dystonia made by a movement disorders specialist.
  • Medically optimized without planned medication changes for the duration of the study.
  • For patients with ET, they will have a score of at least 2 on items 5 and 6 of the Fahn-Tolosa-Marin (FTM) Tremor Rating Scale.
  • For patients with dystonia, they will have abnormal dystonic postures of the head and not isolated head tremor

Exclusion Criteria

  • The presence of additional neurologic diseases, that might confound testing or the coexistence of PD and ET together (action tremor that was present prior to the development of parkinsonism).
  • Symptoms of peripheral neuropathy at the wrist (reduced vibratory, pinprick, or temperature sensation)
  • Montreal cognitive assessment (MoCA) score \< 20 or previously documented dementia
  • Unable to walk without a walking aid (e.g. cane, stick, walker)

Outcomes

Primary Outcomes

Quantitative Tremor Assessment

Time Frame: Baseline up to immediately after the sham intervention

An external accelerometer will be adhered to the skin of the dorsum of the hand and will be used to quantify displacement of the hand due to tremor in the following conditions: * 1. Sitting at rest * 2. Sitting with both arms outstretched * 3. Sitting at rest while performing a distracting cognitive task * 4. Transition from rest to posture (arms held directly in front of patient) for 10 seconds

Secondary Outcomes

  • Functional Dexterity Task (FDT)(Baseline up to immediately after the sham intervention)
  • Timed-up-and-go (TUG) gait task(Baseline up to immediately after the sham intervention)
  • Reaction time task(Baseline up to immediately after the sham intervention)

Study Sites (1)

Loading locations...

Similar Trials